Sangamo showcases progress in our pre-clinical programs at ESGCT.

Sangamo Therapeutics Announces Participation at Jefferies Healthcare Conference

BRISBANE, Calif. --(BUSINESS WIRE)--May 21, 2021-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that management will participate in a fireside chat at the Jefferies Healthcare Conference on Friday, June 4 th at 11am Eastern Time .